The influence of sympathomimetic amines, monoamine oxidase inhibitors, and antihypertensives upon the energy metabolism in the rat heart.
D000227:Adenine Nucleotides / Q000032:analysis*; D000255:Adenosine Triphosphate / Q000032:analysis*; D000661:Amphetamine / Q000494:pharmacology*; D000818:Animals; D001949:Bretylium Compounds / Q000494:pharmacology*; D003913:Dextroamphetamine / Q000494:pharmacology*; D004809:Ephedrine / Q000494:pharmacology*; D006145:Guanethidine / Q000494:pharmacology*; D006321:Heart / Q000187:drug effects*; D066298:In Vitro Techniques; D008694:Methamphetamine / Q000494:pharmacology*; D009206:Myocardium / Q000378:metabolism*; D010725:Phosphocreatine / Q000032:analysis*; D051381:Rats; D012110:Reserpine / Q000494:pharmacology*; D014191:Tranylcypromine / Q000494:pharmacology*; D014439:Tyramine / Q000494:pharmacology*
D000227:Adenine Nucleotides; D001949:Bretylium Compounds; D010725:Phosphocreatine; D014191:Tranylcypromine; D008694:Methamphetamine; D012110:Reserpine; D000255:Adenosine Triphosphate; D000661:Amphetamine; D004809:Ephedrine; D003913:Dextroamphetamine; D014439:Tyramine; D006145:Guanethidine